Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VIEMED HEALTHCARE, INC.VMD · Entity 5824 | Chief Financial Officer | January 29, 2026 | February 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VIEMED HEALTHCARE, INC.
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 105,638 |
Ending reported balance
After 2026-01-29 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-01-29 · Exercise / conversion · Acquired 9,794 · Balance 108,317 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Row 2 · 2026-01-29 · Tax withholding · Disposed 2,679 · Balance 105,638 F2: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3: Per share value is based on the market closing price of the common shares for January 29, 2026. Row 3 · 2026-01-29 · Exercise / conversion · Acquired 3,265 · Balance 108,903 F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Row 4 · 2026-01-29 · Disposition to issuer · Disposed 3,265 · Balance 105,638 F3: Per share value is based on the market closing price of the common shares for January 29, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 9,794 |
Reported balance
After 2026-01-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-29 · Exercise / conversion · Disposed 9,794 · Balance 9,794 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| Phantom Share UnitsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 3,264 |
Reported balance
After 2026-01-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-29 · Exercise / conversion · Disposed 3,265 · Balance 3,264 F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3: Per share value is based on the market closing price of the common shares for January 29, 2026.
F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F6: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2021 Filed Jan 25, 2021 22:43 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantStock Options · Derivative | 42,930 | $0.00 Strike: $8.57 | $0.00 |
DisclosureSEC source: 0001729149-21-000037 · wf-form4_161161461020362.xml · derivative · entry 1 Fitzgerald Trae · CIK 0001782065 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,930 Underlying: Common Shares · 42,930 shares Expires 2031-01-21 F1 · derivative.exercise_date: Options granted to reporting person on January 21, 2021, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:48 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Share Units · Derivative | 28,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001729149-21-000025 · wf-form4_160996971419982.xml · derivative · entry 3 Fitzgerald Trae · CIK 0001782065 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 28,302 shares Expires 2021-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents the right to receive one share of common stock and may be settled in common shares or a cash payment equal to the fair market value of common shares, or a combination thereof. F4 · derivative.exercise_date: On January 4, 2018, the reporting person was granted 84,908 restricted share units vesting as follows: 28,303 on January 4, 2019, 28,303 on January 4, 2020, and 28,302 on January 4, 2021. F4 · derivative.expiration_date: On January 4, 2018, the reporting person was granted 84,908 restricted share units vesting as follows: 28,303 on January 4, 2019, 28,303 on January 4, 2020, and 28,302 on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:48 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 9,432 | $7.86 | $74,135.52 |
DisclosureSEC source: 0001729149-21-000025 · wf-form4_160996971419982.xml · nonDerivative · entry 2 Fitzgerald Trae · CIK 0001782065 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,301 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the January 4, 2021 vesting of 28,302 restricted share units. F3 · price: Per share value is based on the market closing price of the common shares on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:48 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 28,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-21-000025 · wf-form4_160996971419982.xml · nonDerivative · entry 1 Fitzgerald Trae · CIK 0001782065 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents the right to receive one share of common stock and may be settled in common shares or a cash payment equal to the fair market value of common shares, or a combination thereof. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.